@article{43dc523d45314cab8f67b011f6f8921f,
title = "Tyrosine kinase inhibitor levels matter in treating chronic GVHD",
abstract = "We observed a possible concentration effect relationship for nilotinib on resolution of chronic Graft versus Host disease.These data suggest therapeutic drug monitoring might be useful for patients receiving tyrosine kinase inhibitors for chronic GVHD.",
author = "{van der Wagen}, Lotte and Julie Janssen and Reinier Raijmakers and Eefke Petersen and {de Witte}, Moniek and {de Jong}, Niels and Mar Bellido and Ellen Meijer and Brigitte B{\"a}r and {Jan Boelens}, Jaap and Alwin Huitema and Kuball, {J. rgen}",
note = "Funding Information: Acknowledgments We thank Novartis and Roche for kindly providing study medication. This work was further supported in part by grants from the Dutch Cancer Society to LvdW: KWF-UU 2011-5250 and to JK KWF-UU 2010-4669, 2013-6426, 2014-6790, and 2015-7601. Funding Information: Conflict of interest JK is cofounder and scientific advisor of GADETA. His work is partly supported by a grant from Novartis; however, Novartis had no part in the design, analysis, or interpretation of the data or the writing of the manuscript. Publisher Copyright: {\textcopyright} 2019, Springer Nature Limited. Copyright: Copyright 2019 Elsevier B.V., All rights reserved.",
year = "2019",
month = jul,
day = "1",
doi = "10.1038/s41409-018-0429-5",
language = "English",
volume = "54",
pages = "1141--1144",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "7",
}